Elroselabs Inc.

FDA Regulatory Profile

Elroselabs Inc. appears in FDA public data with 3 recalls, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0623-2018, Class II) was initiated on March 28, 2018.

Summary

Total Recalls
3
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0623-2018Class IIConzerol (antipoxin) H2O2 Gel, Hydrogen Peroxide Gel 3%, 1.5 oz. tube, OTC, Manufactured for Elrose March 28, 2018
D-0621-2018Class IIConzerol zero molluscum contagiosum, Topical Cream, Net weight 0.78 (22g), Elrose Labs, Sanford Fl 3March 28, 2018
D-0622-2018Class IIMolleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc.March 28, 2018